Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
FY 2026 first quarter financial results. AZZ reported adjusted net income of $53.8 million or $1.78 per share compared to $44.0 million or $1.46 per share during the prior year period. We had forecast adjusted net income of $50.1 million or $1.66 per share. Compared to the first quarter of FY 2025, sales increased 2.1% to $422.0 million. Adjusted EBITDA increased 13.1% to $106.4 million, representing 25.2% of sales compared to 22.8% of sales during the prior year period. We had projected adjusted EBITDA of $99.5 million.
Meaningful debt reduction. Cash from operations during the fiscal first quarter amounted to $314.8 million, including proceeds of $273.2 million received from AVAIL’s sale of the Electrical Products Group. Following debt reduction of $285.4 million, AZZ ended the quarter with a net leverage ratio of 1.7x TTM adjusted EBITDA. As of May 31, long-term debt, gross was $614.9 million compared to $900.3 million on February 28. Net of unamortized debt issuance costs, long-term debt was $569.8 million on May 31 compared to $852.4 million on February 28.
Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
Middle market companies often sit in a unique sweet spot: large enough to scale and access capital markets, yet small enough to maintain agility and entrepreneurial drive. For investors looking beyond the mega-cap names, these companies can offer strong growth potential and underappreciated value. However, one area where their size shows is in their vulnerability to policy shocks—particularly tariffs.
With the recent news of proposed pharmaceutical import tariffs as high as 200%, there is renewed focus on how U.S. trade and economic policy can affect publicly traded middle market firms. While much of the attention gravitates toward household names in the S&P 500, it is often middle market companies that feel the effects of these shocks most acutely—both in risk and in opportunity.
Why Middle Market Companies Are More Sensitive to Policy Changes
Unlike large-cap multinational corporations, which tend to have well-diversified supply chains and extensive legal and lobbying infrastructure, many mid-sized public companies operate with leaner operations and more concentrated supplier networks. A sudden 25% or 200% tariff on an input or finished product can dramatically alter their cost structure or compress margins.
For example, a middle market pharmaceutical manufacturer importing active ingredients from Asia might not have the domestic sourcing flexibility or pricing power of a top-tier player. Similarly, industrial firms relying on imported steel or semiconductors could find themselves needing to adjust production timelines or renegotiate customer contracts quickly.
Navigating Through the Volatility
Yet these challenges often breed innovation. One strength of middle market firms is their ability to pivot faster than larger peers. When tariffs shift the economics of a product line, smaller public companies often respond with strategic sourcing, nearshoring, or product reengineering at speeds larger bureaucracies struggle to match.
Investors should pay close attention to management’s ability to communicate and execute these adjustments. Companies that respond proactively to tariffs may emerge stronger, with improved operational resilience and competitive differentiation.
A Hidden Advantage: Domestic Focus
Interestingly, many middle market stocks have a geographic advantage when it comes to tariffs. Firms that focus primarily on domestic customers or rely on U.S.-based production may see relatively limited impact from import duties. In fact, some could benefit as competitors with overseas exposure face higher costs or delays.
This potential insulation is particularly relevant in sectors like building materials, specialty manufacturing, and consumer services—all areas where middle market companies often shine.
Long-Term Opportunities for Investors
For long-term investors, the key is to identify which middle market companies are not just reacting, but adapting and innovating in the face of policy changes. These firms may offer compelling upside potential when the dust settles.
Policy shocks like tariffs are not going away. But they don’t necessarily have to derail performance. In many cases, they can highlight hidden strengths—operational flexibility, strategic focus, and leadership that can thrive in uncertainty.
In an era of shifting policy, these resilient middle market growth stocks can be some of the most rewarding investments in the public markets.
Delivers Record Quarterly Sales, Adjusted EBITDA, and Adjusted EPS over Prior Year
Raising Fiscal Year 2026 Guidance on Strong Earnings
FORT WORTH, Texas, July 9, 2025 /PRNewswire/ — AZZ Inc. (NYSE: AZZ), the leading independent provider of hot-dip galvanizing and coil coating solutions, today announced financial results for the first quarter ended May 31, 2025.
Fiscal Year 2026 First Quarter Overview (as compared to prior fiscal year first quarter(1)):
Total Sales of $422.0 million, up 2.1%
Metal Coatings sales of $187.2 million, up 6.0%
Precoat Metals sales of $234.7 million, down 0.8%
$273.2 million cash received from our minority interest in AVAIL related to the sale of the Electrical Products Group to nVent Electric plc
Net Income of $170.9 million, up 331.6%; Adjusted net income of $53.8 million, up 22.3%
GAAP diluted EPS of $5.66 per share, up 510.1%; Adjusted diluted EPS of $1.78, up 21.9%
Adjusted EBITDA of $106.4 million or 25.2% of sales, versus prior year of $94.1 million, or 22.8% of sales
Segment Adjusted EBITDA margin of 32.9% for Metal Coatings and 20.7% for Precoat Metals
Debt reduction of $285 million in the quarter, resulting in net leverage ratio 1.7x
Cash dividend of $0.17 per share to common shareholders paid in the quarter
(1)
Adjusted Net Income, Adjusted EPS, Adjusted EBITDA, and net leverage ratio are non-GAAP financial measures as defined and reconciled in the tables below.
Tom Ferguson, President, and Chief Executive Officer of AZZ, commented, “We are off to a great start in the fiscal year as sales grew to $422.0 million, up 2.1% over the prior year, with Adjusted diluted EPS of $1.78 up 21.9%. Consolidated Adjusted EBITDA grew to $106.4 million, or 25.2% of sales, primarily driven by higher volume for hot-dip galvanized steel and operational productivity over the prior year. Metal Coatings benefited from improved zinc utilization and delivered an Adjusted EBITDA margin of 32.9%. Precoat Metals’ Adjusted EBITDA margin improved to 20.7%, primarily due to favorable mix and improved operational performance. While volumes were slightly lower for Precoat Metals, customer demand improved, as shipments of customer inventories increased compared to first quarter of last year.
Our fiscal first quarter cash from operations of $314.8 million, including proceeds from AVAIL’s sale of the Electrical Products Group, allowed us to reduce debt by $285.4 million. We ended the quarter with a net leverage ratio of 1.7x. Subsequent to the quarter, we successfully closed a bolt-on acquisition within our Metal Coatings segment and announced the increase of our quarterly cash dividend to common shareholders from $0.17 to $0.20 per share. I want to thank all of our dedicated AZZ employees for their hard work, dedicated focus on sales volume, and productivity improvements. Our employees continue to demonstrate their pride and passion for delivering outstanding quality and service to our customers, while driving operational excellence. We are on track to set new profitability records in fiscal year 2026 as we continue to execute on our strategic plans.” Ferguson concluded.
Segment Performance
First Quarter2026Metal Coatings
Sales of $187.2 million increased by 6.0% over the first quarter of last year, primarily due to increased volume supported by infrastructure related project spending in several end markets, including construction, industrial, and electrical transmission and distribution. Segment Adjusted EBITDA of $61.5 million resulted in Adjusted EBITDA margin of 32.9%, on increased volume and improved zinc utilization, an increase of 200 basis points from the prior year first quarter.
First Quarter2026 Precoat Metals
Sales of $234.7 million were 0.8% lower than the first quarter of last year on decreased volume in certain end markets, including construction, HVAC, and appliance. Segment EBITDA of $48.5 million resulted in EBITDA margin of 20.7%, an increase of 50 basis points from the prior year first quarter.
Balance Sheet, Liquidity and Capital Allocation
The Company generated significant operating cash of $314.8 million for the first three months of fiscal year 2026 through improved earnings, which included a distribution of $273.2 million from the AVAIL JV following AVAIL’s sale of its Electrical Products Group, coupled with our disciplined working capital management. At the end of the first quarter, the Company’s net leverage was 1.7x trailing twelve months Adjusted EBITDA. During the first three months of fiscal year 2026, the Company paid down debt of $285.4 million and returned cash to common shareholders through cash dividend payments totaling $5.1 million. Capital expenditures for the first three months of fiscal year 2026 were $20.9 million, including $3.2 million of spending related to the new Washington, Missouri facility, and full fiscal year capital expenditures are expected to be approximately $60 – $80 million. Pursuant to the Company’s existing $100 million Share Repurchase Program, the Company has a remaining balance of $53.2 million available for repurchases.
Financial Outlook — Fiscal Year 2026 Guidance
We are adjusting fiscal year guidance, reflecting confidence in our strategic execution, operational resilience, and market positioning. Fiscal year 2026 guidance reflects our best estimates given anticipated market conditions for the full year, lower interest expense, an annualized effective tax rate of 25% and excludes M&A activity and any federal regulatory changes that may emerge.
FY2026 Guidance(1)
Sales
$1.625 – $1.725 billion
Adjusted EBITDA
$360 – $400 million
Adjusted Diluted EPS
$5.75 – $6.25
(1)
FY2026 Guidance Assumptions:
a.
Excludes any future acquisitions.
b.
Excludes any future equity in earnings from AVAIL joint venture.
c.
Management defines adjusted earnings per share to exclude intangible asset amortization, restructuring charges and additional stock compensation expense related to the adoption of our executive retiree long-term incentive program from the reported GAAP measure.
d.
Assumes EBITDA margin range of 27 – 32% for the Metal Coatings segment and 17% – 22% for the Precoat Metals segment.
Conference Call Details
AZZ Inc. will conduct a live conference call with Tom Ferguson, Chief Executive Officer, Jason Crawford, Chief Financial Officer, and David Nark, Chief Marketing, Communications, and Investor Relations Officer to discuss financial results for the first quarter of the fiscal year 2026, Thursday, July 10, 2025, at 11:00 A.M. ET. Interested parties can access the conference call by dialing (844) 855-9499 or (412) 317-5497 (international). A webcast of the call will be available on the Company’s Investor Relations page at http://www.azz.com/investor-relations.
A replay of the call will be available at (877) 344-7529 or (412) 317-0088 (international), replay access code: 2234808 through July 17, 2025, or by visiting http://www.azz.com/investor-relations for the next 12 months.
About AZZ Inc.
AZZ Inc. is the leading independent provider of hot-dip galvanizing and coil coating solutions to a broad range of end-markets in North America. Collectively, our business segments provide sustainable, unmatched metal coating solutions that enhance the longevity and appearance of buildings, products and infrastructure that are essential to everyday life.
Safe Harbor Statement
Certain statements herein about our expectations of future events or results constitute forward-looking statements for purposes of the safe harbor provisions of The Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by terminology such as “may,” “could,” “should,” “expects,” “plans,” “will,” “might,” “would,” “projects,” “currently,” “intends,” “outlook,” “forecasts,” “targets,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” or the negative of these terms or other comparable terminology. Such forward-looking statements are based on currently available competitive, financial, and economic data and management’s views and assumptions regarding future events. Such forward-looking statements are inherently uncertain, and investors must recognize that actual results may differ from those expressed or implied in the forward-looking statements. Forward-looking statements speak only as of the date they are made and are subject to risks that could cause them to differ materially from actual results. Certain factors could affect the outcome of the matters described herein. This press release may contain forward-looking statements that involve risks and uncertainties including, but not limited to, changes in customer demand for our manufactured solutions, including demand by the construction markets, the industrial markets, and the metal coatings markets. We could also experience additional increases in labor costs, components and raw materials including zinc and natural gas, which are used in our hot-dip galvanizing process, paint used in our coil coating process; supply-chain vendor delays; customer requested delays of our manufactured solutions; delays in additional acquisition opportunities; an increase in our debt leverage and/or interest rates on our debt, of which a significant portion is tied to variable interest rates; availability of experienced management and employees to implement AZZ’s growth strategy; a downturn in market conditions in any industry relating to the manufactured solutions that we provide; economic volatility, including a prolonged economic downturn or macroeconomic conditions such as inflation or changes in the political stability in the United States and other foreign markets in which we operate; tariffs, acts of war or terrorism inside the United States or abroad; and other changes in economic and financial conditions. AZZ has provided additional information regarding risks associated with the business, including in Part I, Item 1A. Risk Factors, in AZZ’s Annual Report on Form 10-K for the fiscal year ended February 28, 2025, and other filings with the SEC, available for viewing on AZZ’s website at www.azz.com and on the SEC’s website at www.sec.gov.
You are urged to consider these factors carefully when evaluating the forward-looking statements herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by this cautionary statement. These statements are based on information as of the date hereof and AZZ assumes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.
Company Contact: David Nark, Chief Marketing, Communications, and Investor Relations Officer AZZ Inc. (817) 810-0095 www.azz.com
Investor Contact: Sandy Martin / Phillip Kupper Three Part Advisors (214) 616-2207 or (817) 368-2556 www.threepa.com
CHICAGO, July 9, 2025 /PRNewswire/ — Titan International, Inc. will release its second quarter 2025 financial results before the opening of the market on Thursday, July 31, 2025 to be followed by a teleconference and webcast on Thursday, July 31, 2025 at 9:00 a.m. Eastern Time.
About Titan: Titan International, Inc. (NYSE: TWI) is a leading global manufacturer of off-highway wheels, tires, assemblies, and undercarriage products. Headquartered in West Chicago, Illinois, the company globally produces a broad range of products to meet the specifications of original equipment manufacturers (OEMs) and aftermarket customers in the agricultural, earthmoving/construction, and consumer markets. For more information, visit www.titan-intl.com.
VANCOUVER, BC, July 9, 2025 – Nicola Mining Inc. (the “Company” or “Nicola”) (TSX: NIM) (OTCQB: HUSIF) (FSE: HLIA) is pleased to announce that it has commenced production of gold and silver concentrate at its wholly owned Merritt Mill, located approximately 15 kilometers from Merritt, British Columbia. In a news release dated July 18, 2024, Nicola announced the processing of a bulk sample mill feed from Talisker Resources Ltd. (TSX: TSK) (OTCQX: TSKFF) (“Talisker”). The current announcement marks the transition to a long-term production plan.
Following extensive upgrades—including automation, gravity separation, and water recirculation systems that underscore the Company’s commitment to the environmental stewardship—Nicola is positioned to become a leading milling hub for high-grade gold and silver in British Columbia. In addition to Talisker, Nicola has entered into a partnership with Blue Lagoon Resources (CSE: BLLG) (OTCQB: BLAGF) (FSE: 7BL) and is preparing to commence bulk sample production atDominion Creek GoldProject, which Nicola holds a 75% economic interest.
On July 7, 2025, Talisker announced the shipment of approximately 3,100 tonnes of high-grade gold ore from the Mustang Project to Nicola’s Merritt Mill (also known as the Craigmont Mill) for processing.
Talisker is actively developing the 1060, 1075, 1105 and 1120 levels. In-vein development is underway on the BK vein at the 1075 level, and both on the BK and BK9870 veins at the 1105 Level.
Talisker also commenced long-hole drilling in preparation for the mining and extraction of the first stope, with extraction expected to begin later this week.
Mr. Peter Espig, CEO of Nicola Mining Inc., commented: “We are extremely pleased to have commenced long-term production with Talisker and recognize the significant achievements made to date. Securing mining permits, raising capital, and executing on a mine plan require dedicated commitment. Nicola’s ability to enter into multiple agreements highlights the strategic importance of our M-68 Mine Permit and underscores British Columbia’s accelerated commitment to advancing wellmanaged mining projects.”
Qualified Person
Cameron Lilly, P. Eng., the Company’s Mill Manager, is the Qualified Person as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects and supervised the preparation of, and has reviewed and approved, the technical information in this release.
About Nicola Mining
Nicola Mining Inc. is a junior mining company listed on the Exchange and Frankfurt Exchange that maintains a 100% owned mill and tailings facility, located near Merritt, British Columbia. It has signed Mining and Milling Profit Share Agreements with high grade gold projects. Nicola’s fully permitted mill can process both gold and silver mill feed via gravity and flotation processes.
The Company owns 100% of the New Craigmont Project, a high-grade copper property, which covers an area of over 10,800 hectares along the southern end of the Guichon Batholith and is adjacent to Highland Valley Copper, Canada’s largest copper mine. The Company also owns 100% of the Treasure Mountain Property, which includes 30 mineral claims and a mineral lease, spanning an area exceeding 2,200 hectares.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
The Federal Reserve is positioning for interest rate cuts in 2025, but internal divisions over timing and magnitude are creating uncertainty that savvy investors can capitalize on. Recent FOMC meeting minutes reveal a central bank walking a tightrope between economic resilience and emerging warning signs. With rates held at 4.25% to 4.5% for the fourth consecutive meeting, Fed officials acknowledge that “most participants assessed that some reduction” would be appropriate before year-end. The drivers are clear: job growth is moderating, consumer spending is weakening, and policymakers believe tariff-related inflation pressures will prove “temporary and modest.”
However, the timeline remains contentious. Some officials floated cuts as early as July’s meeting, while others advocate waiting until 2026. This split reflects conflicting economic signals that make the Fed’s job increasingly complex. The data tells a nuanced story—June’s job growth of 147,000 exceeded expectations, pushing unemployment down to 4.1%, yet consumer spending declined for two consecutive months, and retail sales dropped 0.9% in May, suggesting Americans are pulling back on discretionary purchases. President Trump’s evolving tariff strategy adds another layer of complexity, with fresh threats of 200% duties on pharmaceuticals and shifting trade negotiations creating policy uncertainty, though recent data shows tariffs haven’t significantly impacted consumer prices.
For investors focused on publicly traded middle market companies, this rate environment represents both challenge and opportunity. These firms—typically valued between $100 million and $3 billion—occupy a strategic sweet spot between agile private companies and rate-insulated mega-caps. Middle market companies are particularly sensitive to interest rate changes because they rely more heavily on traditional debt financing for growth, face direct impacts on borrowing costs and capital allocation decisions, and trade at valuation multiples that respond quickly to rate expectations.
If aggressive rate cuts materialize, middle market stocks could experience significant multiple expansion. Lower debt servicing costs would boost margins while improved investor sentiment drives capital toward growth-oriented sectors like technology, manufacturing, and specialty services. Conversely, if cuts are delayed or modest, capital costs remain elevated, pressuring margins and slowing expansion plans. In this scenario, companies with fortress balance sheets and disciplined cash management will outperform leveraged peers.
Despite internal disagreements, the Fed’s message is clear: they’re ready to act when data justifies it. This creates a compelling setup for investors willing to position ahead of the eventual pivot. Middle market stocks with strong fundamentals appear particularly attractive, as rates normalize and these companies could benefit from renewed investor appetite for undervalued growth stories, improved access to capital markets, and enhanced M&A activity as strategic buyers regain confidence.
The Fed’s cautious approach to rate cuts reflects genuine economic uncertainty, but history suggests that patient investors who position during periods of policy transition often capture the most upside. For middle market investors, the current environment offers a rare opportunity to acquire quality companies at reasonable valuations before the market fully prices in lower rates. The key is identifying businesses with strong competitive positions, manageable debt loads, and clear paths to growth once monetary conditions ease. The spotlight is about to return to middle market stocks—the question is whether investors will be ready.
STAMFORD, Conn.–(BUSINESS WIRE)– Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm, said today it will release its second-quarter financial results on Wednesday, August 6, 2025, at approximately 4:15 p.m., U.S. Eastern Time.
The firm will host a conference call with investors and industry analysts at 9 a.m., U.S. Eastern Time, the following day, Thursday, August 7. Dial-in details are as follows:
The dial-in number for U.S. participants is +1 (800) 715-9871.
International participants should call +1 (646) 307-1963.
The security code to access the call is 9414856.
Participants are requested to dial in at least five minutes before the scheduled start time.
A recording of the conference call will be accessible on ISG’s investor relations page for approximately four weeks following the call.
About ISG
ISG (Nasdaq: III) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world’s top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data, in-depth knowledge of provider ecosystems, and the expertise of its 1,600 professionals worldwide working together to help clients maximize the value of their technology investments.
By The Comtech Editorial Team – Jul 9, 2025 | 3 min read
CHANDLER, Ariz. – Jul. 9, 2025– Comtech Telecommunications Corp. (NASDAQ: CMTL) (“Comtech” or the “Company”), a global communications technology leader, today announced three key leadership appointments within its Satellite and Space Communications (“S&S”) segment. These appointments include Steve Black as the new Chief Operating Officer (“COO”), Mark Dale as the new Chief Technology Officer (“CTO”) and Brent Norman as the new Chief Financial Officer (“CFO”); each reporting to Daniel Gizinski, President of Comtech’s S&S segment.
Ken Traub, Chairman and CEO of Comtech, commented, “Under Daniel’s leadership, the transformation of our S&S business is progressing very well, and we are now well-positioned to capitalize on growth opportunities and further improvements in operational execution. We are delighted to have recruited Steve and Brent and promoted Mark to these key leadership roles. These appointments bring together a diverse set of expertise and leadership that will be instrumental in delivering exceptional value to customers worldwide and pursuing strategic initiatives.”
Steve Black, appointed COO of S&S in May 2025, brings nearly three decades of differentiated industry knowledge and operational expertise to Comtech. Prior to joining the Company, he served as Vice President and General Manager of General Dynamics’ Advanced Manufacturing Group, and previously held leadership roles at L3Harris, including Director of Integrated Business Operations for the company’s Commercial Aviation Sector. As COO of S&S, Mr. Black will oversee and optimize all operational processes across the segment, ensuring Comtech continues to reliably deliver advanced, trusted products on accelerated timelines while driving cost-effective production and maintaining exceptional quality standards.
Mark Dale, appointed CTO of S&S in June 2025, brings a deep blend of technical expertise and customer insight gained over nearly three decades in the satellite and broadband wireless communications sectors. Previously serving as a Senior Technical Fellow at Comtech, Dr. Dale has held key leadership positions at Kratos Defense & Security Solutions, Viasat, and Broadcom. In his new role, Dr. Dale will lead engineering teams in designing and deploying next-generation satellite communications solutions while closely partnering with customers to align technology roadmaps and architectures.
Brent Norman, appointed CFO of S&S in June 2025, will lead all financial reporting, planning, budgeting, and analysis efforts, as well as manage investments and ensure regulatory compliance. With an extensive background spanning financial leadership roles at General Dynamics and L3Harris, Mr. Norman will focus on strengthening the segment’s financial foundation and identifying new avenues for value creation.
“Our continued success hinges on exceptional leadership, and I’m thrilled to welcome Steve, Mark, and Brent to these critical roles,” said Daniel Gizinski, President of Comtech’s S&S segment. “Their combined expertise in operations, technology, and finance will be instrumental in driving our strategic transformation, meeting our near-term objectives, and positioning Comtech to achieve long-term growth. With these trusted leaders in place, we are further strengthening our ability to innovate and deliver advanced communications solutions to our global customers.”
These leadership appointments reflect Comtech’s continued commitment to its ongoing transformation strategy, first announced in January 2025, which includes enhancing the operational structure of the S&S segment with a focus on delivering a strategic set of next-generation, mission-critical satellite communications systems to commercial and government customers across the globe.
About Comtech
Comtech Telecommunications Corp. is a leading provider of satellite and space communications technologies; terrestrial and wireless network solutions; Next Generation 9-1-1 (NG9-1-1) and emergency services; and cloud native capabilities to commercial and government customers around the world. Through its culture of innovation and employee empowerment, Comtech leverages its global presence and decades of technology leadership and experience to create some of the world’s most innovative solutions for mission-critical communications. For more information, please visit www.comtech.com.
Forward-Looking Statements
Certain information in this press release contains statements that are forward-looking in nature and involve certain significant risks and uncertainties. Actual results and performance could differ materially from such forward-looking information. The Company’s Securities and Exchange Commission filings identify many such risks and uncertainties. Any forward-looking information in this press release is qualified in its entirety by the risks and uncertainties described in such Securities and Exchange Commission filings.
CHICAGO–(BUSINESS WIRE)– MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced dosing of the first patient in Taiwan in the expansion phase of its THIO-101 Phase 2 trial for advanced non-small cell lung cancer (NSCLC). The trial’s entry into another continent marks a key milestone for MAIA, opening a significantly larger patient pool for its evaluations of ateganosine (THIO). Screening for the trial is ongoing in Europe and Asia.
Trial Design: The expansion study evaluates ateganosine in heavily pre-treated patients in third-line (3L) NSCLC who have previously failed treatment with checkpoint inhibitors (CPIs) and chemotherapy. Two treatment arms are being studied: ateganosine sequenced with cemiplimab (Libtayo®) and ateganosine monotherapy. Regeneron is supplying Libtayo for the combination cohort.
Strategic Opportunity: NSCLC represents one of the largest global oncology indications. The market was valued at $34.1B in 2024, and is projected to reach $68.8B by 2033 with a projected CAGR of 8.1%.1
Current Data: As of May 15, 2025, the median overall survival (OS) for the 22 patients in the third-line treatment was 17.8 months, with a 95% confidence interval (CI) lower bound of 12.5 months and a 99% CI lower bound of 10.8 months. The treatment has been generally well-tolerated in the trial’s heavily pre-treated population.2
Other studies of chemotherapy for NSCLC in a similar setting have shown overall survival of 5-6 months.3
“We are excited to have the expansion of the trial officially started. Ateganosine’s observed OS in third-line NSCLC exceeds all known benchmarks,” said MAIA’s Chief Executive Officer Vlad Vitoc, M.D. “This potentially positions us for first-mover advantage in a multibillion-dollar space with no currently approved standard of care.”
About Ateganosine
Ateganosine (THIO, 6-thio-dG or 6-thio-2’-deoxyguanosine) is a first-in-class investigational telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). Telomeres, along with the enzyme telomerase, play a fundamental role in the survival of cancer cells and their resistance to current therapies. The modified nucleotide 6-thio-2’-deoxyguanosine induces telomerase-dependent telomeric DNA modification, DNA damage responses, and selective cancer cell death. Ateganosine-damaged telomeric fragments accumulate in cytosolic micronuclei and activates both innate (cGAS/STING) and adaptive (T-cell) immune responses. The sequential treatment with ateganosine followed by PD-(L)1 inhibitors resulted in profound and persistent tumor regression in advanced, in vivo cancer models by induction of cancer type–specific immune memory. Ateganosine is presently developed as a second or later line of treatment for NSCLC for patients that have progressed beyond the standard-of-care regimen of existing checkpoint inhibitors.
About THIO-101, a Phase 2 Clinical Trial
THIO-101 is a multicenter, open-label, dose finding Phase 2 clinical trial. It is the first trial designed to evaluate ateganosine’s anti-tumor activity when followed by PD-(L)1 inhibition. The trial is testing the hypothesis that low doses of ateganosine administered prior to cemiplimab (Libtayo®) will enhance and prolong immune response in patients with advanced NSCLC who previously did not respond or developed resistance and progressed after first-line treatment regimen containing another checkpoint inhibitor. The trial design has two primary objectives: (1) to evaluate the safety and tolerability of ateganosine administered as an anticancer compound and a priming immune activator (2) to assess the clinical efficacy of ateganosine using Overall Response Rate (ORR) as the primary clinical endpoint. The expansion of the study will assess overall response rates (ORR) in advanced NSCLC patients receiving third line (3L) therapy who were resistant to previous checkpoint inhibitor treatments (CPI) and chemotherapy. Treatment with ateganosine followed by cemiplimab (Libtayo®) has been generally well-tolerated to date in a heavily pre-treated population. For more information on this Phase II trial, please visit ClinicalTrials.gov using the identifier NCT05208944.
About MAIA Biotechnology, Inc.
MAIA is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. Our lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. For more information, please visit www.maiabiotech.com.
Forward-Looking Statements
MAIA cautions that all statements, other than statements of historical facts contained in this press release, are forward-looking statements. Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause our or our industry’s actual results, levels or activity, performance or achievements to be materially different from those anticipated by such statements. The use of words such as “may,” “might,” “will,” “should,” “could,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “project,” “intend,” “future,” “potential,” or “continue,” and other similar expressions are intended to identify forward-looking statements. However, the absence of these words does not mean that statements are not forward-looking. For example, all statements we make regarding (i) the initiation, timing, cost, progress and results of our preclinical and clinical studies and our research and development programs, (ii) our ability to advance product candidates into, and successfully complete, clinical studies, (iii) the timing or likelihood of regulatory filings and approvals, (iv) our ability to develop, manufacture and commercialize our product candidates and to improve the manufacturing process, (v) the rate and degree of market acceptance of our product candidates, (vi) the size and growth potential of the markets for our product candidates and our ability to serve those markets, and (vii) our expectations regarding our ability to obtain and maintain intellectual property protection for our product candidates, are forward looking. All forward-looking statements are based on current estimates, assumptions and expectations by our management that, although we believe to be reasonable, are inherently uncertain. Any forward-looking statement expressing an expectation or belief as to future events is expressed in good faith and believed to be reasonable at the time such forward-looking statement is made. However, these statements are not guarantees of future events and are subject to risks and uncertainties and other factors beyond our control that may cause actual results to differ materially from those expressed in any forward-looking statement. Any forward-looking statement speaks only as of the date on which it was made. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. In this release, unless the context requires otherwise, “MAIA,” “Company,” “we,” “our,” and “us” refers to MAIA Biotechnology, Inc. and its subsidiaries.
1 Custom Market Insights, Global NSCLC Drug Market Size Likely to Surpass at a CAGR of 8.1% By 2033, Apr. 2024 2 Details on safety can be found on the previously announced SITC 2024 presentation available on MAIA’s website. 3 Girard N, et al. J Thorac Onc 2009;12:1544-1549.
President Donald Trump announced on Tuesday his intention to impose tariffs of up to 200% on imported pharmaceutical products, a move that could dramatically reshape the pharmaceutical landscape. While the tariffs would not go into effect immediately, the president indicated they could be implemented “very soon,” with a grace period of roughly a year to a year and a half for companies to adapt.
The proposed tariffs come as part of a broader economic strategy aimed at bolstering domestic manufacturing and reducing U.S. reliance on foreign pharmaceutical production. Trump has long criticized the pharmaceutical industry for outsourcing production, and this latest proposal aligns with his “America First” trade agenda. The administration believes steep tariffs would incentivize companies to bring more manufacturing operations back to the United States.
Commerce Secretary Howard Lutnick confirmed that the final details of the pharmaceutical tariffs will be revealed by the end of July, following the conclusion of studies on pharmaceuticals and semiconductors currently under Section 232 of the Trade Expansion Act. This legal framework allows the administration to impose trade barriers on national security grounds—one of the same avenues used for previous tariffs on steel and aluminum.
Pharmaceutical companies and industry groups reacted swiftly to the announcement. Major firms, including Eli Lilly, Johnson & Johnson, and AbbVie, have warned that such a move could lead to unintended consequences. Critics argue the tariffs would raise the cost of essential medicines, disrupt global supply chains, and potentially limit access to critical drugs for patients.
Industry leaders have also expressed concern that the new tariffs could stifle innovation by diverting funds away from research and development. The pharmaceutical sector is already under pressure from other regulatory changes related to drug pricing and reimbursement models. Adding steep tariffs into the mix, they argue, could further destabilize long-term investment in life-saving therapies.
Despite these concerns, Trump maintains that the threat of tariffs is a powerful lever to revive American manufacturing. While some large pharmaceutical companies have increased domestic investment in recent years, U.S.-based drug production still represents only a fraction of global output. Trump’s administration believes that tough economic measures are necessary to reverse decades of offshoring.
Notably, pharmaceutical stocks remained relatively stable in the immediate aftermath of the announcement, reflecting skepticism among investors about whether the tariffs will ultimately materialize or reach the proposed 200% threshold. Trump has previously floated similar trade measures that were later scaled back or delayed.
Still, the mere possibility of such tariffs signals a growing willingness to use aggressive trade policy in sectors traditionally considered too sensitive or complex for broad economic intervention. The coming weeks will likely bring more clarity as the administration finalizes its review and industry stakeholders prepare for what could be a major policy shift.
If enacted, these tariffs would mark one of the most consequential moves in U.S. healthcare trade policy in decades—potentially reshaping supply chains, pricing, and the geopolitical landscape of pharmaceutical production.
Vancouver, British Columbia–(Newsfile Corp. – July 8, 2025) – Hemisphere Energy Corporation (TSXV: HME) (OTCQX: HMENF) (“Hemisphere” or the “Company”) is pleased to announce that the TSX Venture Exchange (the “TSXV”) has accepted the Company’s Notice of Intention to renew of its Normal Course Issuer Bid (the “NCIB”) to purchase for cancellation, from time to time, as Hemisphere considers advisable, up to 7,934,731 common shares (“Common Shares”) of the Company, representing approximately 10% of the current “public float” of the Common Shares.
Purchases of Common Shares will be made on the open market through the facilities of the TSXV. For any Common Shares purchased, Hemisphere will pay the prevailing market price of the Common Shares. The actual number of Common Shares that may be purchased for cancellation and the timing of any such purchases will be determined by the Company and dependent on market conditions.
The Company is commencing the NCIB because it believes that, from time to time, the market price of its Common Shares may not properly reflect the underlying, intrinsic value of the Company, and that, at such times, the purchase of Common Shares for cancellation will increase the proportionate interest of, and be advantageous to, all remaining shareholders.
The NCIB will commence on July 14, 2025 and will terminate on July 13, 2026 or at such earlier time as the NCIB is completed or terminated at the option of Hemisphere. The Company has retained Canaccord Genuity Corp. as its broker to conduct the NCIB on its behalf.
Under the Company’s previous normal course issuer bid, the Company sought and received approval of the TSXV to purchase 8,255,766 Common Shares for the period from July 14, 2024 to July 13, 2025. During that period, the Company purchased 3,624,700 Common Shares on the open market at a weighted-average price of $1.793 per Common Share.
About Hemisphere Energy Corporation
Hemisphere is a dividend-paying Canadian oil company focused on maximizing value-per-share growth with the sustainable development of its high netback, ultra-low decline conventional heavy oil assets through polymer flood enhanced oil recovery methods. Hemisphere trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol “HME” and on the OTCQX Venture Marketplace under the symbol “HMENF”.
For further information, please visit the Company’s website at www.hemisphereenergy.ca to view its corporate presentation or contact:
Don Simmons, President & Chief Executive Officer Telephone: (604) 685-9255 Email: info@hemisphereenergy.ca
Note Regarding Forward-Looking Statements and Other Advisories
This document contains forward-looking information. This information relates to future events and the Company’s future performance. All information and statements contained herein that are not clearly historical in nature constitute forward-looking information, and the words “may”, “will”, “should”, “could”, “expect”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “propose”, “predict”, “potential”, “continue”, “aim”, or the negative of these terms or other comparable terminology are generally intended to identify forward-looking information. Such information represents the Company’s internal projections, estimates, expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance. This information involves known or unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. Hemisphere believes that the expectations reflected in this forward-looking information are reasonable; however, undue reliance should not be placed on this forward-looking information, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. This news release contains forward-looking information concerning, among other things, the timing of the NCIB, the anticipated advantages of the NCIB to Hemisphere’s shareholders and the Company’s business strategy, the price to be paid by Hemisphere for purchases of Common Shares under the NCIB and Hemisphere’s plans for maximizing value per share growth with the sustainable development of its high netback high netback, low decline conventional heavy oil assets through polymer flood enhanced recovery methods. The reader is cautioned that such information, although considered reasonable by the Company, may prove to be incorrect. A number of risks and other factors could cause actual results to differ materially from those expressed in the forward-looking information contained in this document including, but not limited to, the risk that the anticipated benefits of the NCIB may not be achieved and the risk that the Company may not be able to successfully execute its business strategy or growth plans. Readers are cautioned that the foregoing list of factors is not exhaustive. Although the forward-looking statements contained in this document are based upon assumptions which management of Hemisphere believes to be reasonable, Hemisphere cannot assure investors that actual results will be consistent with these forward-looking statements. With respect to forward-looking statements contained in this document, Hemisphere has made assumptions regarding, among other things, the ability of Hemisphere to fund purchases of Common Shares under the NCIB and its business strategy. These forward-looking statements are made as of the date of this document and Hemisphere disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
PURCHASE, N.Y., July 08, 2025 (GLOBE NEWSWIRE) — Townsquare Media, Inc. (NYSE: TSQ) (“Townsquare” or the “Company”) announced today that it will release second quarter 2025 financial results before the market opens on Wednesday, August 6, 2025. The Company will host a conference call to discuss certain second quarter 2025 financial results on Wednesday, August 6, 2025 at 8:00 a.m. Eastern Time.
The conference call dial-in number is 1-800-717-1738 (U.S. & Canada) or 1-646-307-1865 (International) and the conference ID is “Townsquare.” A live webcast of the conference call as well as the press release disclosing the Company’s results will be available on the investor relations page of the Company’s website at www.townsquaremedia.com.
A telephone replay of the conference call will be available through August 13, 2025. To access the replay, please dial 1-844-512-2921 (U.S. & Canada) or 1-412-317-6671 (International) and enter confirmation code 1173163. A web-based archive of the conference call will also be available on the investor relations page of the Company’s website.
About Townsquare Media, Inc. Townsquare is a community-focused digital and broadcast media and digital marketing solutions company principally focused outside the top 50 markets in the U.S.Townsquare Ignite, our robust digital advertising division, specializes in helping businesses of all sizes connect with their target audience through data-driven, results based strategies, by utilizing a) our proprietary digital programmatic advertising technology stack with an in-house demand and data management platform and b) our owned and operated portfolio of more than 400 local news and entertainment websites and mobile apps along with a network of leading national music and entertainment brands, collecting valuable first party data. Townsquare Interactive, our subscription digital marketing services business, partners with SMBs to help manage their digital presence by providing a SAAS business management platform, website design, creation and hosting, search engine optimization and other digital services. And through our portfolio of local radio stations strategically situated outside the Top 50 markets in the United States, we provide effective advertising solutions for our clients and relevant local content for our audiences. For more information, please visit www.townsquaremedia.com, www.townsquareinteractive.com, and www.townsquareignite.com.
Parrot Uncle is a World Leading Ceiling Fan and Home Décor Manufacturer Selling Millions of Ceiling Fans in the U.S. and Global Markets
Ceiling Fans and Space Heaters Category Represents a Multi-Billion-Dollar Annual Market with Tens of Millions of Units Sold in the U.S. Alone
SKYX Anticipates Q3 Winter Global Launch Will Support its Path to Cash-Flow Positive in 2025
MIAMI, July 08, 2025 (GLOBE NEWSWIRE) — SKYX Platforms Corp. (NASDAQ: SKYX) (“SKYX” or the “Company”), a highly disruptive smart home platform technology company with over 100 issued and pending patents globally and a growing portfolio of over 60 lighting and home décor websites, with a mission to make homes and buildings become smart, safe, and advanced as the new standard, today announced a U.S. and global sales and marketing collaboration agreement with Parrot Uncle, a world leading ceiling fan and home décor manufacturer selling millions of fans globally.
SKYX and Parrot Uncle will jointly market SKYX’s disruptive technologies and products in the U.S. and to global markets including its patented all-in-one smart turbo heater & ceiling fan.
The ceiling fan and space heater category represents a multi-billion-dollar annual market with tens of millions of units sold in the U.S. alone.
In response to the strong demand, SKYX will introduce two different versions of the product each in 6 to 8 colors, designed to meet both residential and commercial needs. Production has officially begun with the Company’s manufacturing partners, and SKYX anticipates a broad launch in Q3 2025, aligned with the upcoming winter season.
This highly innovative product—integrating a ceiling fan with a built-in heater—is designed to address a massive market opportunity for all four seasons. The combined ceiling fan and portable heater category is a multi-billion-dollar market, with tens of millions of units sold annually in the U.S. alone.
The Company believes that the successful launch of this product line is a critical milestone on its path toward achieving cash-flow positive operations in 2025.
Rani Kohen, Founder and Executive Chairman of SKYX Platforms Corp., stated: “This sales and collaboration agreement with Parrot Uncle is strategic for both U.S. and global markets. This exemplifies our commitment to global strategic relationships based on our innovation, safety, and global market products. As we prepare for our upcoming launch, we believe this breakthrough all-in-one heater ceiling fan solution will drive significant value for our customers, partners, and shareholders.”
To view SKYX’s technologies in action, click here: CLICK HERE
About SKYX Platforms Corp.
As electricity is a standard in every home and building, our mission is to make homes and buildings become safe-advanced and smart as the new standard. SKYX has a series of highly disruptive advanced-safe-smart platform technologies, with over 100 U.S. and global patents and patent pending applications. Additionally, the Company owns over 60 lighting and home decor websites for both retail and commercial segments. Our technologies place an emphasis on high quality and ease of use, while significantly enhancing both safety and lifestyle in homes and buildings. We believe that our products are a necessity in every room in both homes and other buildings in the U.S. and globally. For more information, please visit our website at https://skyplug.com/ or follow us on LinkedIn.
Forward-Looking Statements
Certain statements made in this press release are not based on historical facts, but are forward-looking statements. These statements can be identified by the use of forward-looking terminology such as “aim,” “anticipate,” “believe,” “can,” “could,” “continue,” “estimate,” “expect,” “evaluate,” “forecast,” “guidance,” “intend,” “likely,” “may,” “might,” “objective,” “ongoing,” “outlook,” “plan,” “potential,” “predict,” “probable,” “project,” “seek,” “should,” “target” “view,” “will,” or “would,” or the negative thereof or other variations thereon or comparable terminology, although not all forward-looking statements contain these words. These statements reflect the Company’s reasonable judgment with respect to future events and are subject to risks, uncertainties and other factors, many of which have outcomes difficult to predict and may be outside our control, that could cause actual results or outcomes to differ materially from those in the forward-looking statements. Such risks and uncertainties include statements relating to the Company’s ability to successfully launch, commercialize, develop additional features and achieve market acceptance of its products and technologies and integrate its products and technologies with third-party platforms or technologies; the Company’s efforts and ability to drive the adoption of its products and technologies as a standard feature, including their use in homes, hotels, offices and cruise ships; the Company’s ability to capture market share; the Company’s estimates of its potential addressable market and demand for its products and technologies; the Company’s ability to raise additional capital to support its operations as needed, which may not be available on acceptable terms or at all; the Company’s ability to continue as a going concern; the Company’s ability to execute on any sales and licensing or other strategic opportunities; the possibility that any of the Company’s products will become National Electrical Code (NEC)-code or otherwise code mandatory in any jurisdiction, or that any of the Company’s current or future products or technologies will be adopted by any state, country, or municipality, within any specific timeframe or at all; risks arising from mergers, acquisitions, joint ventures and other collaborations; the Company’s ability to attract and retain key executives and qualified personnel; guidance provided by management, which may differ from the Company’s actual operating results; the potential impact of unstable market and economic conditions on the Company’s business, financial condition, and stock price; and other risks and uncertainties described in the Company’s filings with the Securities and Exchange Commission, including its periodic reports on Form 10-K and Form 10-Q. There can be no assurance as to any of the foregoing matters. Any forward-looking statement speaks only as of the date of this press release, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by U.S. federal securities laws.
View original content to download multimedia:
